Recent and remote spatial memory in mice treated with cytosine arabinoside.
Clinical studies suggest that chemotherapy is associated with long-term cognitive impairment in some patients. A number of underlying mechanisms have been proposed, however, the etiology of chemotherapy-related cognitive dysfunction remains relatively unknown. As part of a multifaceted approach, animal models of chemotherapy-induced cognitive impairment are being developed. Thus far, the majority of animal studies have utilized a rat model, however, mice may prove particularly beneficial in studying genetic risk factors for developing chemotherapy-induced cognitive impairment. Various chemotherapy agents, including cytosine arabinoside (Ara-C), have been found to impair remote spatial memory in rats in the Morris water maze. The present study evaluated the effects of Ara-C on remote (30 d) spatial memory in mice. In addition, the possibility that time relative to chemotherapy treatment may modulate the effect of chemotherapy on spatial learning and/or recent (1 d) memory was explored. Male C57BL/6J mice received either Ara-C (275 mg/kg i.p. daily for 5 days) or saline. Spatial learning and memory was assessed using the Morris water maze. Half the mice performed a remote (30 d) memory version of the task and the other half performed a recent (1 d) memory version of the task. The experiment was designed such that the probe trial for the recent memory version occurred on the same day relative to chemotherapy treatment as the remote memory version. Despite significant toxic effects as assessed by weight loss, Ara-C treated mice performed as well as control mice during acquisition, recent memory, and remote memory portions of the task. As are some humans, C57BL/6J mice may be resistant to at least some aspects of chemotherapy induced cognitive decline.
Dept. of Psychology, University of Maine, Orono, ME 04469-5742, USA. thane.fremouw@umit.maine.edu
Thane
T
Fremouw
Christy L
CL
Fessler
Robert J
RJ
Ferguson
Yamil
Y
Burguete
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001522:Behavior, Animal / Q000187:drug effects; D003561:Cytarabine / Q000009:adverse effects*; D004195:Disease Models, Animal; D008297:Male; D018782:Maze Learning; D008568:Memory / Q000187:drug effects*; D008569:Memory Disorders / Q000139:chemically induced*; D051379:Mice; D008810:Mice, Inbred C57BL; D011897:Random Allocation; D013037:Spatial Behavior / Q000187:drug effects; D013997:Time Factors; D015431:Weight Loss / Q000187:drug effects
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine